<DOC>
	<DOCNO>NCT02312596</DOCNO>
	<brief_summary>A prospective , randomize , control , clinical study establish clinical base evidence Eclipse PRP™ compare performance usual customary practice treatment Wagner 1 2 DFUs .</brief_summary>
	<brief_title>A Prospective , Randomized Clinical Trial ECLIPSE PRP™ Wound Biomatrix Non-Healing Diabetic Foot Ulcers</brief_title>
	<detailed_description>This prospective , randomize , single-blind , control , multi-center study subject undergo DFU treatment . Qualified subject randomize ( 1:1 ) ; test group ( Eclipse PRP™ Wound Biomatrix ) control group ( usual customary practice ) . The study consist 3 period : screening period , active treatment period , follow-up period ( heal ) . Approximately 250 subject enrol . Subjects ≥18 year age chronic Wagner grade 1 2 DFU ( great 1 month duration ) . Each subject enrol active treatment period 12 week , closure wind confirmatory visit 2 week wound closure , whether closure occur 12 week earlier .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Medicare eligible A full thickness diabetic foot ulcer viable wound bed Diabetes mellitus ( type I II ) adequately control The ulcer great 4 week duration . The large nonhealing wound , multiple wound present , single wound treat ( index ulcer ) Wagner 1 2 DFU ( see Appendix Wagner Classification ) locate plantar , medial , lateral aspect foot ( include toe surface heel ) . Postdebridement , ulcer size must 0.5 20 cm2 . One follow assessment complete confirm pedal circulation : ankle / brachial index 0.7 1.2 ; transcutaneous partial pressure oxygen ( TcPO2 ) &gt; 30 mmHg ankle ; toe pressure &gt; 40mm Hg doppler waveform consistent adequate flow foot ( biphasic triphasic ) Able willing provide voluntary write informed consent . Able willing wear offload device orthopedic shoe Able willing attend schedule followup visit study relate exams Greater 30 % reduction wound size first two week observation treatment investigator Wagner 3 , 4 , 5 DFU Gross clinical infection study ulcer site include cellulitis osteomyelitis Wounds likely require dressing change frequent twice weekly ( heavy exudate ) . Known allergy tor sensitivity Eclipse PRP kit component ( calcium chloride , calcium gluconate acid citrate dextrose solution A ( ACDA ) ) Presence Gangrene Active Charcot 's disease determine clinical radiographic examination nondiabetic pathophysiology ( e.g. , rheumatoid , radiationrelated , vasculitis related ulcer ) Malignancy near ulcer site Known serum albumin &lt; 2.5 mg/dl , Known renal failure determine Creatinine &gt; 2.5 mg/dl , Plasma Platelet count le 100 x 109/L , Hemoglobin le 10.5 g/dL Rheumatoid arthritis ( collagen vascular disease ) , vasculitis , sickle cell disease , HIV Severe liver disease . Severe liver disease define known history chronic hepatitis cirrhosis &amp; /or follow abnormal Liver Function Tests : ALT &amp; AST &gt; 35 , ALP &gt; 120 , PT &gt; 12 second . Presence additional abnormal lab value obtain within 7 day prior Day 0 visit determine clinically significant investigator include : WBC &gt; 13,000/cm3 &lt; 5 , 000 cm3 , electrolytes outside host institution 's range normal . Radiation therapy , chemotherapy , chronic steroid use immunosuppressive therapy within 30 day enrollment Received another investigational device drug within 30 day enrollment Received allograft , autograft xenograft within 30 day enrollment Subject inadequate venous access repeat blood draw require Eclipse RPR administration Subject require anticipated require intervention direct improvement arterial perfusion affect area . Ulcer expect treated advanced therapeutic ( e.g. , HBOT ) Any condition judge investigator would cause study detrimental subject Alcohol drug abuse , define current medical treatment substance abuse Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>non-healing wound</keyword>
	<keyword>diabetic foot ulcer</keyword>
	<keyword>platelet rich plasma</keyword>
</DOC>